Huiyong Yin Lab


  • Dr. Shanshan Zhong

    shazhong@cityu.edu.hk

    Dr. Zhong obtained her PhD degree from the University of Chinese Academy of Sciences (CAS), Shanghai Institute of Nutrition and Health in 2020. She joined New York University (NYU) Langone Hospital and Yale school of Medicine separately as a visiting student and postgraduate researcher, respectively, from 2019 to 2020. She continued her postdoctoral training at the Center for Excellence in Molecular Biology, CAS, from 2021 to 2022, before joining the Department of Biomedical sciences at City University of Hong Kong in 2023. Her research interest focuses on investigating spatio-temporal regulations of metabolic enzymes in metabolic diseases and cancer.


Dr. Yongqiang Wang

wangyongqiang2020@sinh.ac.cn

Post-doctral (2025-)

PhD student (2020-2025)

Thesis project: Fructose metabolism and liver cancer

B.S. (2017-2021): Shanghai Normal University

Dr. Zhuoya Fang

zhuoyafang@whu.edu.cn

Post-doctral (2026-)

Research interests: RNA splicing and tumor metabolic reprogramming

Ph.D. (2019-2025): Wuhan University
M.S. (2016-2019): Southwest University
B.S. (2012-2016): Henan University of Technology

Dr. Thashma Pemmanda Ganapathy

thashmapg@gmail.com

Post-doctral (2026-)

Research interests: Immunometabolism and Metainflammation

Ph.D. (2021-2025): The Hong Kong Polytechnic University
Research Postgraduate Student (2016-2018): University of Auckland, New Zealand


Haoran Ma

mahaoran2021@sinh.ac.cn

PhD student (2021-)

Thesis project: Fructose-1,6-bisphosphate aldolase in adipose tissues

B.S. (2017-2021): East China University of Science and Technology

Hualing Xu

xhualing2-c@my.cityu.edu.hk

PhD student (2023-)

Thesis project: fructose metabolism through gut-liver axis in HCC

M.S. (2020-2023): Nanjing University of Traditional Chinese Medicine

B.S. (2016-2020): Chengdu University of Traditional Chinese Medicine

Xiangnan Chen

xiancheng3-c@my.cityu.edu.hk

PhD student: (2022-)

Thesis project: spatiotemporal metabolic reprogramming mediated by metabolic enzymes

B.S. (2018-2022): Northwest Agriculture and Forestry University

Hongfei Wang

hfwang8-c@my.cityu.edu.hk

PhD student: (2023-)

Thesis project: metabolomic enzymes in cell cycle

M.S. (2020-2023) China Pharmaceutical University

B.S. (2016-2020): Guangzhou University of Chinese Medicine

Xiangyang Zhang

xzhang4349-c@my.cityu.edu.ck

Joint PhD student (2023-)

City University of Hong Kong and Central South University

Thesis project: Metabolic basis of cancer immunity and immunotherapy

M.S. (2020-2023): Xiangya Hospital, Central South University

B.S. (2015-2020): Xiangya School of Medicine, Central South University

Yingchao Liang

yliang348@gapps.cityu.edu.hk

PhD student: (2025-)

Interests: Metabolomic alterations in metabolic diseases

M.S.(2022-2025): Guangzhou University of Chinese Medicine
B.S.(2017-2022): Guangzhou University of Chinese Medicine

Shiqi Wang

wangshiqi1418@163.com

PhD student candidate (2026-)

Research Interests: The impact of liver cancer on the intestines

M.S. (2024-2026) : Sichuan University
B.S. (2019-2024) : Northeast Agricultural University


Sakshi SHRIVASTAVA

sshrivast5@cityu.edu.hk

She is dedicated to contributing and advancing in the field of science.

B.S. (2020-2024): City University of Hong Kong

Mingxia He

yolanda_77an@163.com

Research interests: The Role And Mechanism Of Serine In Regulating Macrophage Phagocytosis In Sepsis

M.S. (2022-2025): Henan University
B.S. (2014.09-2018.06): Chengdu Medical College

Yusheng Zhou

yushezhou7@cityu.edu.hk

Research interests: Embryonic development and cell cycle

M.S. (2020 – 2023): University of Chinese Academy of Sciences
B.S. (2016 – 2020): Jinan University


Research Faculty:

Dr. Yongzhen Tao (2013-2023)

Dr. Lin XIA (2012-2016)

Lab Manager:

Ms. Junhong WANG (2011-2016)

Ms. Shiting CHEN (2016-2024)

PhD students

Dr. Rui Li (2020-2025): Metabolomics and machine learning in hyperuricemia and gout

Dr. Huimin Jiang (2020-2025): Diabetes

Dr. Xin Chen (2019-2024): Cardiovascular disease

Dr. Jingwen Lv(2019-2024): ALDH2 and macrophage

Dr. Lili ZHANG (2018-2024): ALDH2 and liver cancer

Dr. Xiaodong XU (2018-2024): ALDH2-medidated inflammation in atherosclerosis

Dr. Qiaochu TU (2018-2024): Metabolic Reprogramming in HCC by Hepatic Nuclear Factor 4a (HNF4a)

Dr. Ningning LIANG (2017-2023): Interplay of purine and lipid metabolism

Dr. Chunzhao YIN (2017-2023): epigenetic regulation of immune responses in HCC

Dr. Ningning WANG (2016-2022): fructose metabolism in HCC

Dr. Luxiao LI (2016-2021): ALDH2 and HDL

Dr. Guijun LIU (2016-2021): Insulin signaling in HCC

Dr. Xia SHEN (2015-2020): metabolomics in Hyperuricemia and gout

Dr. Xuxiao HE (2014-2019): ALDOB and AKT in HCC

Dr. Min LI (2013-2019): ALDOB and G6PD in HCC

Dr. Shuyuan GUO (2013-2018): Oxidized cholesterol esters in atherosclerosis

Dr. Jing GE (2012-2018): dynamic network biomarkers in atherosclerosis

Dr. Jianhong LU (2011-2017): oxidized phospholipids in atherosclerosis

Dr. Huiqin ZHONG (2011-2017): Cardiolipin metabolism in HCC

Dr. Rina SA (2010-2015): lipid metabolism in NAFLD and HCC

MS students:

Chenxi Du (2022-2024): Gut microbiota metabolism

Xinben WEI (2012-2016): DNA oxidative modification derived from lipid peroxidation

Xinli XUE (2014-2017): acetaminophen and lipid metabolism

Qun CHEN (2014-2017):TiO2 Nanoparticles and Macrophage Function

Mengqin XIAO (2014-2017): Cardiolipin Metabolism in HCC

Yujuan ZHUO (2014-2017): Hepatic Nuclear Factor 4a in HCC metabolic reprogramming

Research Assistant:

Mr. Yuanzhe Wang (2024-2025)

Mr. Mingjiang ZHU (2011-2017)

Ms. Qianqian CHU (2013-2017)